Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer
about
Lipocalin-7 is a matricellular regulator of angiogenesisPGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.Proteomic analysis of human aqueous humor using multidimensional protein identification technology.Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.Cystatin C is a disease-associated protein subject to multiple regulation.Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.Cystatin 9 and C: A novel immunotherapy that protects against multi-drug resistant New Delhi metallo-beta-lactamase-1 producing Klebsiella pneumoniae.Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report.Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden
P2860
Q33749832-2DB4D1C8-64D7-4B1C-8A6F-C0E38127AB87Q33752909-E1F82FA3-4C32-4681-916E-6BC7E512FA6EQ34887552-F55D7A54-3362-42C7-A8E4-A83DF2517392Q35490960-EFCECC6A-8FA8-4F02-A6CA-21827C050BA5Q37476824-97281224-5086-4607-A4A2-77FBCCBBBC4AQ37918451-42CAE136-F47B-4C03-80B0-B000561813E4Q38341202-715862C6-BAF3-4542-8961-70F9B02F43B5Q41051406-6DCD6BA8-C282-4C44-B39B-06371B0BE2A3Q46797867-3471572B-AF55-42AC-9D8A-82DE13AFB75EQ47327683-EC990B23-6180-4AC1-9D22-07DEB43769DBQ51498595-EBE3CA54-3365-4185-AD8B-ECEF3ECD9D88Q57788837-826A4D37-1949-4134-8656-4A4A4F832837
P2860
Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@ast
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@en
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@nl
type
label
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@ast
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@en
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@nl
prefLabel
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@ast
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@en
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@nl
P2860
P356
P1476
Preclinical efficacy of cystat ...... h factor Beta in breast cancer
@en
P2093
Maozhen Tian
William P Schiemann
P2860
P304
P356
10.1593/TLO.09145
P407
P577
2009-08-18T00:00:00Z